RLMD
Relmada Therapeutics, Inc. · Healthcare
Chief Executive Officer Sergio Traversa bought $828K of Relmada Therapeutics, Inc.
Bought$828,000
$4.14Price
200,000Shares
+15%Stake
What RLMD did for a copier
- $1,000 copied at Fri, Sep 11 open, $4.60
- $698
- S&P 500, same days
- +1.1%
28 of 30 trading days so far, to the Oct 21 close.
Sergio Traversa's record
7 other buys with 3 months of prices since 2022: on average +56.4% against the S&P 500, and 3 of 7 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Sep 9. Filed Fri, Sep 11, 7:30 AM ET, before the open. Returns use the Sep 11 open and the Oct 21 close. Not investment advice.